- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA Releases New Data on Workplace Equality
Workplace equality accelerating for healthcare industry’s Gender Parity Collaborative.
The Gender Parity Collaborative, an award-winning consortium led by the Healthcare Businesswomen’s Association (HBA), has released a report presenting new data marking the significant headway their healthcare and life- sciences partner companies are making towards gender and workplace equality, outperforming peers and various industries altogether.
Insights and Impact 2021 details progress and achievements made during a two-year period, from the consortium’s founding in 2018 through 2020, including substantial increases in women’s representation specifically in leadership roles at the VP level and above.
Read more about the report here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
